CXCR5 and myelodysplastic syndrome: The expression of PD1 on CD4+CXCR5+ cells was decreased in MDS patients with AI (4.09 ± 2.49%) than in MDS patients without AI (7.84 ± 5.28%) (P < 0.05) (Figure 1).